Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Partial Hepatectomy and Ablation for Survival of Early-Stage Hepatocellular Carcinoma Patients: A Bayesian Emulation Analysis

Life(2024)10.3390/life14060661Source: DataRank Database

Partial Hepatectomy and Ablation for Survival of Early-Stage Hepatocellular Carcinoma Patients: A Bayesian Emulation Analysis is a research paper published in Life (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.00)OA: goldTopics (30)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Yunju Im ORCID,Rong Wang ORCID,Shuangge Ma ORCID,Jiping Wang ORCID

Live enrichment

PubMed:38929645 OpenAlex:https://openalex.org/W4398203087

National Institutes of Health

Grant: HL161691

National Institutes of Health

Grant: CA276790

NCI NIH HHS

Grant: R03 CA276790

NHLBI NIH HHS

Grant: R21 HL161691

NCATS NIH HHS

Grant: UL1 TR001863

National Institutes of Health

Grant: 1R21HL161691-01A1

Deep Learning-based Emulation Analysis: Methodological Developments and Case Studies

National Institutes of Health

Grant: 1R03CA276790-01A1

Cancer Emulation Analysis with Deep Neural Network

FWCI

0.00

Citation Percentile

0.1%

goldLicense: cc-by

journalhttps://doi.org/10.3390/life14060661

publisherhttps://doi.org/10.3390/life14060661

publisherhttps://www.mdpi.com/2075-1729/14/6/661/pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38929645

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11204969

Fields of Study

Hepatocellular Carcinoma Treatment and PrognosisLiver Disease Diagnosis and TreatmentCholangiocarcinoma and Gallbladder Cancer Studies03 medical and health sciences0302 clinical medicine

Keywords

MedicineHepatocellular carcinomaHepatectomyHazard ratioStage (stratigraphy)AblationConfidence intervalCohortProportional hazards modelInternal medicineSurvival analysisSurgerySorafenibOncologyRadiologyResectionBiologyHCCComparative EffectivenessSeer-medicareTarget Trial EmulationBayesian SurvivalScienceQArticle

Sustainable Development Goals

SDG 0: Good health and well-being